Dr. Aliya L. Frederick, MD, PHD
Child Neurology (Neurology with Special Qualifications in Child Neurology Physician)
8001 Frost St
San Diego, CA 92123
Who else practices at this address →
San Diego County includes primary care (1% of residents) and mental health (1% of residents) shortage areas. About shortage areas
At a glance
- In the NPI registry since
- 2015
Licensed in California since 2017, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology with Special Qualifications in Child Neurology Physician primary
CA license A148160 (first issued 2017; current) -
Clinical Neurophysiology Physician
CA license A148160 (first issued 2017; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Payments from drug and device companies
In 2025, 5 companies reported 23 payments worth $5,441 in total to this clinician.
| UCB, Inc. | $5,206 |
|---|---|
| Teva Pharmaceuticals USA, Inc. | $101 |
| Neurelis, Inc. | $64.63 |
| Biocodex, Inc. | $41.33 |
| Acadia Pharmaceuticals Inc | $27.68 |
| Consulting Fee | $3,600 |
|---|---|
| Travel and Lodging | $1,026 |
| Food and Beverage | $815 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Mar 10, 2025 | Consulting Fee Fintepla · Neurology | $3,600 |
| UCB, Inc. Feb 21, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX · in-kind | $818 |
| UCB, Inc. Feb 21, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX · in-kind | $184 |
| UCB, Inc. Mar 17, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX | $23.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $7,708 in research payments for these studies, mostly to the institutions running them.
- Phase 3 multicenter randomized doubleblind group sequential placebocontrolled study to assess efficacy and safety of rimegepant for the treatment of migraine with or without aura in children and adolescents 6 to 18 …
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.